Dineen SP - Search Results

1

Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts.

Roland CL, Dineen SP, Lynn KD, Sullivan LA, Dellinger MT, Sadegh L, Sullivan JP, Shames DS, Brekken RA. Roland CL, et al. Among authors: dineen sp. Mol Cancer Ther. 2009 Jul;8(7):1761-71. doi: 10.1158/1535-7163.MCT-09-0280. Epub 2009 Jun 30. Mol Cancer Ther. 2009. PMID: 19567820

2

Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative.

Beal EW, Srinivas S, Shen C, Kim A, Johnston FM, Greer J, Abbott DE, Pokrzywa C, Raoof M, Grotz TE, Leiting JL, Fournier K, Dineen S, Powers B, Veerapong J, Kothari A, Maduekew U, Maithel S, Wilson GC, Patel SH, Lambert L, Abdel-Misih S, Cloyd JM. Beal EW, et al. Ann Surg Oncol. 2023 Mar;30(3):1840-1849. doi: 10.1245/s10434-022-12753-0. Epub 2022 Oct 30. Ann Surg Oncol. 2023. PMID: 36310315

3

Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPEC.

Kubi B, Nudotor R, Fackche N, Rowe J, Cloyd JM, Ahmed A, Grotz TE, Fournier K, Dineen S, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Dhar V, Lambert L, Abbott DE, Pokrzywa C, Raoof M, Lee B, Zaidi MY, Maithel SK, Johnston FM, Greer JB. Kubi B, et al. J Surg Oncol. 2023 Mar;127(4):706-715. doi: 10.1002/jso.27147. Epub 2022 Dec 5. J Surg Oncol. 2023. PMID: 36468401

4

[No title available]

[No authors listed] [No authors listed] PMID: 36418799

5

A peptoid "antibody surrogate" that antagonizes VEGF receptor 2 activity.

Udugamasooriya DG, Dineen SP, Brekken RA, Kodadek T. Udugamasooriya DG, et al. Among authors: dineen sp. J Am Chem Soc. 2008 Apr 30;130(17):5744-52. doi: 10.1021/ja711193x. Epub 2008 Apr 2. J Am Chem Soc. 2008. PMID: 18386897

6

Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice.

Dineen SP, Lynn KD, Holloway SE, Miller AF, Sullivan JP, Shames DS, Beck AW, Barnett CC, Fleming JB, Brekken RA. Dineen SP, et al. Cancer Res. 2008 Jun 1;68(11):4340-6. doi: 10.1158/0008-5472.CAN-07-6705. Cancer Res. 2008. PMID: 18519694

7

The acellular fraction of stored platelets promotes tumor cell invasion.

Dineen SP, Roland CL, Toombs JE, Kelher M, Silliman CC, Brekken RA, Barnett CC Jr. Dineen SP, et al. J Surg Res. 2009 May 1;153(1):132-7. doi: 10.1016/j.jss.2008.04.013. Epub 2008 May 7. J Surg Res. 2009. PMID: 18541268

8

The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer.

Dineen SP, Sullivan LA, Beck AW, Miller AF, Carbon JG, Mamluk R, Wong H, Brekken RA. Dineen SP, et al. BMC Cancer. 2008 Nov 27;8:352. doi: 10.1186/1471-2407-8-352. BMC Cancer. 2008. PMID: 19038046 Free PMC article.

9

Pancreatoduodenectomy with or without pyloric preservation: a clinical outcomes comparison.

Dineen SP, Roland CL, Schwarz RE. Dineen SP, et al. HPB Surg. 2008;2008:719459. doi: 10.1155/2008/719459. Epub 2009 Jan 29. HPB Surg. 2008. PMID: 19197376 Free PMC article.

10

Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue.

Halberg N, Khan T, Trujillo ME, Wernstedt-Asterholm I, Attie AD, Sherwani S, Wang ZV, Landskroner-Eiger S, Dineen S, Magalang UJ, Brekken RA, Scherer PE. Halberg N, et al. Mol Cell Biol. 2009 Aug;29(16):4467-83. doi: 10.1128/MCB.00192-09. Epub 2009 Jun 22. Mol Cell Biol. 2009. PMID: 19546236 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page